Manage stand orders
Select Option
Advertisement
Belgian Volition SPRL
Rue Phocas Lejeune, 22,
5032
Isnes
Belgium
Belgium
This company is co-exhibitor of
AWEX - Wallonia Export & Investment
Location
Hall map
Fairground map
Our range of products
Product categories
- 03 Diagnostic Tests
- 03.02 Immunochemistry testing, immunology testing
- 03.02.01 Immuno assay testing
Immuno assay testing
- 03 Diagnostic Tests
- 03.02 Immunochemistry testing, immunology testing
- 03.02.03 Diagnostic tests for cancer
Diagnostic tests for cancer
About us
Company details
Brighter tomorrow
The dedicated team at Volition have a shared goal – to save lives by revolutionizing the way disease, and especially cancer, is diagnosed throughout the world.
Early diagnosis is key
Cancer is the second leading cause of death and is responsible for 1-in-6 deaths worldwide each year. It is widely accepted that the best way of tackling cancer is for patients to receive an early diagnosis, as this improves their chances of surviving cancer. Volition is developing simple, easy to use blood-based tests to diagnose a range of cancers and other diseases.
We believe that Nu.Q™ will provide a low-cost routine blood test allowing doctors to check off an extra box along with other routine blood tests, such as cholesterol and PSA, during a single visit, and that this is currently the only credible way of taking compliance with screening above 80%.
The dedicated team at Volition have a shared goal – to save lives by revolutionizing the way disease, and especially cancer, is diagnosed throughout the world.
Early diagnosis is key
Cancer is the second leading cause of death and is responsible for 1-in-6 deaths worldwide each year. It is widely accepted that the best way of tackling cancer is for patients to receive an early diagnosis, as this improves their chances of surviving cancer. Volition is developing simple, easy to use blood-based tests to diagnose a range of cancers and other diseases.
We believe that Nu.Q™ will provide a low-cost routine blood test allowing doctors to check off an extra box along with other routine blood tests, such as cholesterol and PSA, during a single visit, and that this is currently the only credible way of taking compliance with screening above 80%.